MORPHOLOGICAL MANIFESTATIONS OF ACTION OF THYROCALCITONIN IN EXPERIMENTAL D2 HYPERVITAMINOSIS

被引:0
|
作者
ODINOKOV.VA
ERSHOV, VN
SPIRICHE.VB
SUMAROKO.DD
ZELICHEN.MI
BAYANDUR.MN
BRISKIN, AI
BLAZHEEV.NV
机构
来源
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:119 / +
页数:1
相关论文
共 50 条
  • [21] KIDNEY FUNCTION AND STRUCTURE IN EXPERIMENTAL HYPERPARATHYROIDISM AND HYPERVITAMINOSIS D
    ENGFELDT, B
    LAGERGREN, C
    GARDELL, S
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA, 1962, (154): : 59 - &
  • [22] HYPERVITAMINOSIS-D IN SHEEP - EXPERIMENTAL-STUDY
    SIMESEN, MG
    HANICHEN, T
    DAMMRICH, K
    ACTA VETERINARIA SCANDINAVICA, 1978, 19 (04) : 588 - &
  • [23] D2 or not D2? The gastrectomy question
    Lewis W.G.
    Edwards P.
    Barry J.D.
    Khan S.
    Dhariwal D.
    Hodzovic I.
    Allison M.C.
    Shute K.
    Gastric Cancer, 2002, 5 (1) : 29 - 34
  • [24] OBSERVATIONS ON EFFECT OF EXPERIMENTAL ENDOCRINE PROCEDURES ON TERATOGENIC ACTION OF HYPERVITAMINOSIS A IN RAT
    COHLAN, SQ
    STONE, SM
    BIOLOGIA NEONATORUM, 1961, 3 (06): : 330 - &
  • [25] Mechanisms of inverse agonist action at D2 dopamine receptors
    Roberts, DJ
    Strange, PG
    BRITISH JOURNAL OF PHARMACOLOGY, 2005, 145 (01) : 34 - 42
  • [26] Antipsychotic action with low D2 occupancy:: A study of quetiapine
    Jones, C
    Kapur, S
    Zipursky, RB
    Remington, G
    Shammi, CM
    Houle, S
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 242 - 242
  • [27] Mechanism of action of quetiapine: modulation of dopamine at the D2 receptor
    Goldstein, JM
    EUROPEAN PSYCHIATRY, 2004, 19 : 179S - 179S
  • [28] The role of extrastriatal D2/3 receptors in antipsychotic action
    Gruender, G.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 52 - 53
  • [29] Mechanism of action of quetiapine: A modulator of dopamine at the D2 receptor
    Goldstein, JM
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 311 - 311
  • [30] Mechanism of action of quetiapine: A modulator of dopamine at the D2 receptor
    Goldstein, JM
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 204S - 205S